Executive Director

Chiung-Tong Chen, Ph.D.

POSITION:

• • • • • Executive Director,  National Health Research Institutes Forum (2022.03.01~)
        • Investigator Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes
        • Adjunct professor, The Institute of Molecular Medicine, National Tsing Hua University
        • Associate professor, Institute of Life Sciences, National Defense Medical Center

EDUCATION:

• Ph.D., Pharmaceutics and Pharmaceutical Chemistry, Ohio State University, USA (1992-1997)
• M.S., Pharmacology, National Yang-Ming University, Taiwan (1986-1988)
• B.S., Pharmacy, China Medical University, Taiwan (1981-1986)

PROFESSIONAL EXPERIENCES:

• Director ( September 2017-August 2020)
  Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan.
• Associate Director (February 2012 – August 2017)
  Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan.
• Investigator (October 2010 – present)
  Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan.
• Associate Investigator (2003 – 2010)
  Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan.
• Assistant Investigator (1999 – 2003)
  Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan.
• Interim Secretary General (March 2011 – November 2011; December 2017-January 2018)
  National Health Research Institutes, Miaoli, Taiwan.
• Director, Laboratory Animal Center (March 2005 – June 2009)
  National Health Research Institutes, Miaoli, Taiwan.
• Chairman, Institutional Animal Care and Use Committee (IACUC) (2002 – present)
  National Health Research Institutes, Miaoli, Taiwan.
• President(理事長, 2016-2019)
  The Chinese-Taipei Society of Laboratory Animal Sciences(中華實驗動物學會), Taipei, Taiwan.
• Vice President (2012 – 2015)
  The Chinese-Taipei Society of Laboratory Animal Sciences(中華實驗動物學會), Taipei, Taiwan.
• Member, Board of Executive Directors(理事/常務理事, 2004-present)
  The Chinese-Taipei Society of Laboratory Animal Sciences(中華實驗動物學會), Taipei, Taiwan.
• Adjunct Professor (August 2016 – June 2018)
  Department of Biological Science and Technology, China Medical University, Taichung, Taiwan.
• Jointly Appointed Professor (November 2016 – present)
  Department of Biotechnology, National Chiao Tung University, Hsinchu, Taiwan.
• Adjunct Professor (August 2012 – present)
  Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan
• Jointly Appointed Professor (January 2012 – present)
• Adjunct Associate Professor (2006 – 2011), Adjunct Assistant Professor (2002 – 2006)
  Institute of Life Science, National Defense Medical Center, Taipei, Taiwan.
• Adjunct Assistant Professor (2003 – 2012)
  Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan.
• Member, Board of Directors (董事, 2003 – August 2005)
  Bio 21 Venture Capital Corporation (千禧生技創業投資股份有限公司), Taipei, Taiwan.
• Visiting Scientist (1999)
  Shionogi BioResearch Corp., Lexington, MA, USA.
• Research Associate (1997 – 1999)
  Department of Pharmacology, James H. Quillen College of Medicine
  East Tennessee State University, Johnson City, Tennessee, USA.
• Graduate Research Associate (1992 – 1997)
  Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy
  The Ohio State University, Columbus, Ohio, USA.
• Assistant Research Fellow (1992)
  Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
• Vice Researcher (1990 – 1991), Pharmacist (1991)
  Institute of Research and Development, China Chemical & Pharmaceutical Group, Taipei, Taiwan.

RESEARCH INTERESTS

Dr. Chen considers “Translational Medicine Research” a broad research field covering from basic to clinical researches that ultimately benefit patients in all aspects and, therefore, his research interests have covered a broad spectrum from basic research to drug discovery and development such as the identification of tumor metastasis-associated molecules, establishment of diseased animal models (against cancer, diabetic, and infectious diseases) and discovery and development of new drugs. Dr. Chen is a licensed pharmacist equipped with a broad professional disciplinary scope covering pharmacology, cancer biology, pharmacokinetics, and pharmacodynamics, pharmaceutics, neuroscience, molecular cell biology, laboratory animals, and drug discovery and development. All research activities leading to the discovery and development of clinical therapeutics and advancement of clinical treatments are his major research interests.